Antithrombin levels related to infections and outcome

Journal of Trauma - Injury, Infection and Critical Care

Volumn 40, Issue 3, 1996, Pages 384-387

  Wilson, Robert F ^a   Mammen, Eberhard F ^a   Tyburski, James G ^a   Warsow, Karyn M ^a   Kubinec, Susan M ^a  

^a DETROIT RECEIVING HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN;

ADULT; ARTICLE; HUMAN; INFECTION; INJURY SCALE; MAJOR CLINICAL STUDY; MORTALITY; PREDICTION; PRIORITY JOURNAL; SEPSIS;

EID: 0029981299     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/00005373-199603000-00010     Document Type: Article

References (19)

1. Aasen AO, Smith EN, Amundsen E: Uncontrolled plasma proteolysis: A major treat to the septicemia patient. Resuscitation 14:33, 1986
2. Grundmann R, Hornung M: Follow-up of infected patients in an intensive care unit using the infection score, endotoxin and AT III determination. Langenbecks Arch Chir 73:166, 1988
3. Buller HR: Ten Cate JW: Acquired antithrombin III deficiency: Laboratory diagnosis, incidence, clinical implications and treatment with antithrombin III concentrate. Am J Med 87(suppl 3B):44s, 1989
4. Sandset PM, Roise O, Aasen AI, Abildgaard U: Extrinsic pathway inhibitor in postoperative/posttraumatic septicemia colon increased levels in fatal cases. Haemostasis 19:189, 1989
5. Fourrier F, Lestavel P, Chopin C, et al: Meningococcemia and purpura fulminans in adults: Acute deficiencies of proteins C and S and early treatment with antithrombin III concentrates. Intensive Care Med 16:1, 1990
6. Fourrier F, Chopin C, Huart JJ, et al: Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 104:882, 1993
7. Schuster HP: AT III in septicemia with DIC. Intensive Care Med 19(suppl):S16, 1993
8. Hallgren M, Egberg N, Eklund J: Blood coagulation and fibrinolytic factor and their inhibitors in critically ill patients. Intensive Care Med 10:23, 1984
9. Jordan RE, Kilpatrick J, Nelson RM: Heparin promotes the inactivation of antithrombin by elastase. Science 237:777, 1987
10. Seitz R, Wolf M, Egbring R, Havemann K: The disturbance of hemostasis in septic shock: Role of neutrophil elastase and thrombin, effects of antithrombin III and plasma substitution. Eur J Haematol 43:22, 1989
11. Wilson RF, Mammen EF, Robson MC, et al: Antithrombin, prekallikrein and fibronectin levels in surgical patients. Arch Surg 121:635, 1986
12. Wilson RF, Farag A, Mammen EF, Fujii Y: Sepsis and antithrombin III, prekallikrein and fibronectin levels in surgical patients. Am Surg 55:450, 1989
13. Mammen EF, Miyakawa T, Phillips TF, et al: Human antithrombin concentrates and experimental disseminated intravascular coagulation. Semin Thromb Hemost 11:373, 1985
14. Bone RC: Toward an epidemiology and natural history of SIRS (Systemic Inflammatory Response Syndrome). JAMA 268:3452, 1992
15. Horan TC, Gaynes RP, Martone WJ et al: CDC definitions of nosocomial surgical site infections. Am J Infect Control 20:271, 1992
16. Flinn WR, McDaniel MD, Yao JST, et al: Antithrombin III deficiency as a reflection of dynamic protein metabolism in patients undergoing vascular reconstruction. J Vasc Surg 1:888, 1984
17. Emerson TE, Fournel MA, Redens TB, Taylor FB: Efficacy of antithrombin III supplementation in animal models of fulminant E coli endotoxin or bacteremia. Am J Med 87(suppl 3B):27S, 1989
18. Redens TB, Emerson TE: Antithrombin UT treatment limits disseminated intra-vascular coagulation in endotoxemia. Circ Shock 28:49, 1989
19. Vinazzer H: Therapeutic use of antithrombin III in shock and disseminated intra-vascular coagulation. Semin Thromb Hemost 15:347, 1989